India Market Entry for a US Healthtech Company Targeting Hospital Procurement
Client Archetype
A US-headquartered Series C healthtech company (~USD 35M ARR domestically) evaluating India market entry as its first international expansion. Hospital procurement targeting; needed a structured market-entry plan covering entity structure, go-to-market, regulatory, and the first 18 months of operations.
The Situation
The company had received unsolicited inbound from three large Indian hospital groups and concluded that India was strategically necessary, not optional. The leadership team had no India operating experience and the prior advisor had delivered a market-sizing report with no operating plan. Specifically:
- ●No clarity on entity structure: branch, subsidiary, joint venture, or licensing — each with different tax and regulatory implications.
- ●Hospital procurement cycles in India differ materially from US — committee-based, longer, and price-sensitive in ways that change the GTM motion.
- ●Pricing strategy designed for US market would not survive Indian procurement; per-bed and per-procedure pricing models needed evaluation.
- ●Founding team needed clarity on whether to hire a country lead in month 1 or month 12.
- ●Compliance footprint for medical-software classification under CDSCO / DPDPA needed to be mapped before product was deployed.
The Approach
A 12-week market entry engagement structured in four workstreams running in parallel:
Workstream 1 (Weeks 1–4): Entity & Tax Structure
- ●Comparative analysis: WOS vs. branch vs. JV vs. licensing model.
- ●Singapore HoldCo evaluation under Singapore–India DTAA for tax efficiency.
- ●Coordination with Indian Chartered Accountant for FEMA filings.
- ●Coordination with appointed Indian legal counsel on incorporation specifics.
Workstream 2 (Weeks 2–8): GTM Plan
- ●Hospital segmentation: corporate chains, single-hospital, government, tier-2 cities.
- ●Buying-committee mapping per segment (CMO, CIO, Finance, Procurement).
- ●Pricing models tested against three pilot hospital references.
- ●Channel design: direct vs. distributor vs. SI partner.
Workstream 3 (Weeks 4–10): Regulatory & Data
- ●Medical software classification under CDSCO Medical Device Rules.
- ●DPDPA 2023 personal-data handling design before deployment.
- ●Hospital data-residency requirements and contracting positions.
- ●Coordination with Indian regulatory consultants for filings.
Workstream 4 (Weeks 8–12): Operating Plan & Hiring
- ●First-18-month operating plan with hiring sequence (country lead, sales, CS, technical).
- ●Office-vs.-virtual decision with cost modelling.
- ●Salary benchmarking and equity design for India hires.
- ●90-day post-launch governance cadence with US headquarters.
The Outcome
Engagements of this type typically deliver:
- ●Clear entity recommendation with tax-efficient structure under SG–India DTAA.
- ●Sales motion validated against real hospital buying-committee feedback before launch.
- ●Regulatory clearance pathway mapped before product is deployed.
- ●First-18-month operating plan with hiring sequence and governance cadence.
- ●Founding team confident on the first three high-leverage hires in-market.